More good news from Pfizer. All efficacy endpoints were met. 94% efficacy in the 65+ group. Let's get this to the people. EUA application 'within days'. https://t.co/kyxXUCmKRl— Florian Krammer (@florian_krammer) November 18, 2020
More good news from Pfizer. All efficacy endpoints were met. 94% efficacy in the 65+ group. Let's get this to the people. EUA application 'within days'. https://t.co/kyxXUCmKRl